Cell and gene therapies harbor great hopes for biomedicine. They are becoming increasingly important for diseases that are ...

Patients diagnosed with acquired (autoimmune) hemophilia, a serious and rare bleeding disorder, have high rates of hospital ...

VIJAYAWADA: The State government is committed to ensuring uninterrupted care for citizens with rare and chronic disorders ...

Hemophilia is a rare disorder in which the blood does not clot properly. It affects around 1 in 10,000 people, mostly males ...

Results of a real-world study that included people with hemophilia from 33 countries show that people with hemophilia B, especially those with inhibitors, have the greatest unmet need.

Joint bleeding represents one of the most problematic and painful manifestations of hemophilia A. These hemorrhages typically affect weight-bearing joints including knees, ankles, and elbows.

A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.

EMERYVILLE, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...

While heavy menstrual bleeding is often the key symptom on record, hemophilia carriers may also suffer from joint and muscle bleeding, in addition to obstetric bleeding. “Hemophilia carriers were ...

and Hemophilia B (deficiency of factor IX). Repeated bleeding episodes erode joint tissues, leading to chronic pain, stiffness, and eventually, irreversible disability. India is home to the 2nd ...

joint swelling, and pain due to internal bleeding. Timely diagnosis is key to managing hemophilia. It is often detected in infancy or early childhood through blood tests that check clotting factor ...

Qfitlia (fitusiran), the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringe Unique ...